Yevgen Ryeznik

Senior Lecturer/Associate Professor

Uppsala University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yevgen Ryeznik is a Senior Lecturer and Associate Professor at Uppsala University in Sweden. His research focuses on clinical trial methodologies, including randomization methods, statistical efficiency in trial designs, and the impact of patient engagement in randomized controlled trials. Recent publications include studies on optimizing study designs for rare neurological disorders and the application of pharmacometrics in modern drug development.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Andrew Hooker

Professor of Pharmacometrics

Uppsala University

SWEDEN

View details

france Mentré

INSERM

FRANCE

View details

Weng Kee Wong

Professor

UCLA

UNITED STATES

View details

Ralf-Dieter Hilgers

RWTH Aachen University

GERMANY

View details

Ruth Knight

University of Oxford

UNITED KINGDOM

View details

Elin Svensson

Professor

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yevgen Ryeznik

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A Pharmacometrics‐Informed Trial Simulation Framework for Optimizing Study Designs for Disease‐Modifying Treatments in Rare Neurological Disorders

Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations

Balancing the Objectives of Statistical Efficiency and Allocation Randomness in Randomized Controlled Trials

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial

Steady‐state statistical properties and implementation of randomization designs with maximum tolerated imbalance restriction for two‐arm equal allocation clinical trials

Which Randomization Methods Are Used Most Frequently in Clinical Trials? Results of a Survey by the Randomization Working Group

Accounting for Patient Engagement in Randomized Controlled Trials Evaluating Digital Cognitive Behavioral Therapies

Pharmacometrics meets statistics—A synergy for modern drug development

Practical Treatment of the Multicollinearity: The Optimal Ridge Method and the Modified OLS

On Optimal Designs for Clinical Trials: An Updated Review

Collaborators (6)

Andrew Hooker

france Mentré

Weng Kee Wong

Ralf-Dieter Hilgers

Ruth Knight

Elin Svensson

Make your next move.